Kif15-IN-2

CAS No. 672926-33-9

Kif15-IN-2( —— )

Catalog No. M32983 CAS No. 672926-33-9

Kif15-IN-2 is a kinesin Kif15 inhibitor with potential anticancer activity and can be used in prostate cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Kif15-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    Kif15-IN-2 is a kinesin Kif15 inhibitor with potential anticancer activity and can be used in prostate cancer research.
  • Description
    Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15, and is used for the research of cellular proliferative diseases.
  • In Vitro
    Kif15-IN-2 (Compound 14) is an inhibitor of the mitotic kinesin Hs Kif15, with the potential activities against cellular proliferative diseases such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Kinesin
  • Recptor
    Kinesin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    672926-33-9
  • Formula Weight
    440.48
  • Molecular Formula
    C20H20N6O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 20 mg/mL (45.41 mM; Ultrasonic )
  • SMILES
    CC(C)[C@@H](C(=O)Nc1nc(C)c(s1)-c1nnc(C)o1)n1c(=O)[nH]c2ccccc2c1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Quinazolinedione derivatives useful for treating cellular proliferative disorders and disorders associated with Kif15 kinesin activity are described. US 20040053948 A1.
molnova catalog
related products
  • SB-743921

    SB-743921 is a potent, selective kinesin spindle protein (KSP) inhibitor with Ki of 0.1 nM.

  • Monastrol (b)

    A potent, specific, allosteric and reversible mitotic kinesin Eg5 inhibitor with IC50 of 14 uM (microtubule motility inhibition).

  • WZ8040

    WZ8040 is a novel mutant-selective irreversible EGFRT790M inhibitor, does not inhibit ERBB2 phosphorylation (T798I).